The FMR1 Gene Fragile X Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the FMR1 gene, which are indicative of Fragile X Syndrome (FXS). This condition is a genetic disorder that causes a range of developmental problems including learning disabilities and cognitive impairment. The test is particularly crucial for individuals with a family history of FXS or those showing symptoms of the disorder. By analyzing a sample of the individual's DNA, the test identifies variations in the CGG repeat length within the FMR1 gene, which are responsible for causing the syndrome. The cost of the FMR1 Gene Fragile X Syndrome Genetic Test at DNA Labs UAE is 4400 AED, making it a valuable resource for families seeking answers about this inheritable condition. Early diagnosis through this test can lead to better management and support for those affected by Fragile X Syndrome.
The FMR1 Gene Fragile X Tremor Ataxia Syndrome (FXTAS) Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the FMR1 gene. This gene is crucial because alterations in its structure are associated with Fragile X Tremor Ataxia Syndrome, a condition that affects the nervous system, leading to symptoms such as tremors, problems with movement and balance (ataxia), and cognitive impairments. The test is particularly important for individuals who have a family history of FXTAS or related disorders, as it can provide valuable information for managing and understanding the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the FMR1 gene. Conducting this test at DNA Labs UAE ensures that patients receive reliable results, thanks to the lab's commitment to high-quality standards and its use of advanced genetic testing technologies.
The FXN Gene Friedreich Ataxia Genetic Test is a specialized diagnostic tool used to identify mutations in the FXN gene, which are responsible for Friedreich's ataxia, a rare inherited disease. This condition affects the nervous system and causes movement problems, and it can also lead to heart disease. The test is crucial for early diagnosis, which can aid in managing symptoms and planning for the necessary care and interventions.
Performed at DNA Labs UAE, the test involves analyzing a sample of the patient's DNA to look for specific genetic alterations associated with the condition. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the presence of the FXN gene mutations. This test is an important step for families with a history of Friedreich's ataxia, offering them crucial information for genetic counseling and decision-making regarding their health and future.
The FLNA Gene Frontometaphyseal Dysplasia Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the FLNA gene, which are responsible for Frontometaphyseal Dysplasia (FMD). FMD is a rare genetic disorder characterized by abnormalities in the development of the skeletal system and the muscles, leading to distinctive facial features, skeletal malformations, and other systemic complications. The FLNA gene plays a crucial role in cell structure and movement, and mutations in this gene can disrupt the normal development of bones and other tissues.
This genetic test involves analyzing the patient's DNA to detect mutations in the FLNA gene that are indicative of Frontometaphyseal Dysplasia. It is a critical tool for confirming a diagnosis of FMD, enabling appropriate medical management and genetic counseling for affected individuals and their families.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the FLNA Gene Frontometaphyseal Dysplasia Genetic Test is 4400 AED. This comprehensive test is conducted under stringent quality control measures to ensure accurate and reliable results, providing essential information for the diagnosis and management of Frontometaphyseal Dysplasia.
The FUCA1 Gene Fucosidosis Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the FUCA1 gene, which are responsible for the rare lysosomal storage disorder known as Fucosidosis. This condition is characterized by the body's inability to break down and eliminate fucose-containing substances due to a deficiency in the enzyme alpha-L-fucosidase, leading to a wide range of symptoms including developmental delay, growth retardation, and neurological deterioration.
Performed at DNA Labs UAE, this genetic test is a crucial tool for confirming the diagnosis of Fucosidosis, allowing for early intervention and management of the condition. The test involves analyzing the patient's DNA sample for specific mutations in the FUCA1 gene, providing insights into the severity of the enzyme deficiency and potential implications for the patient's health.
The cost of the FUCA1 Gene Fucosidosis Genetic Test at DNA Labs UAE is 4400 AED. This investment is essential for families seeking clarity on this genetic condition, enabling healthcare providers to tailor treatment and support strategies to improve the quality of life for individuals with Fucosidosis.
Fukuyama Congenital Muscular Dystrophy (FCMD) is a severe genetic disorder primarily affecting muscle function and development, leading to muscle weakness and brain and eye abnormalities. It is caused by mutations in the FKTN gene, which plays a crucial role in maintaining muscle cell integrity. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose FCMD and identify the specific FKTN gene mutations, a genetic test is available at DNA Labs UAE. This test involves analyzing the patient's DNA to search for mutations in the FKTN gene that are known to cause the condition. It is a critical step for confirming the diagnosis, understanding the disease's progression, and informing family planning decisions.
The cost of the FKTN Gene Fukuyama Congenital Muscular Dystrophy Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable resource for families affected by or at risk of FCMD, providing them with essential information for managing the condition and planning for the future.
The "ROBO3 Gene Gaze Palsy Horizontal with Progressive Scoliosis Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the ROBO3 gene. These mutations are linked to a rare neurological disorder characterized by horizontal gaze palsy and progressive scoliosis, a condition where patients are unable to move their eyes horizontally and develop a sideways curvature of the spine that worsens over time. This genetic test plays a crucial role in the early detection and management of the disorder, enabling healthcare professionals to devise appropriate treatment plans and offer genetic counseling to affected families. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify the genetic anomaly associated with this condition.
The "KCNMA1 Gene Generalized Epilepsy and Paroxysmal Dyskinesia Genetic Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the KCNMA1 gene. Mutations in this gene are known to be associated with a range of neurological conditions, including generalized epilepsy and paroxysmal dyskinesia. These disorders are characterized by recurrent seizures and involuntary movements, respectively, which can significantly impact an individual's quality of life.
This genetic test involves analyzing the patient's DNA to detect abnormalities in the KCNMA1 gene, providing crucial information for accurate diagnosis and tailored treatment planning. It is particularly beneficial for individuals who exhibit symptoms of these conditions or have a family history of related neurological disorders.
The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to perform the analysis. Conducted at DNA Labs UAE, a leading facility in genetic testing, patients can expect high-quality service and reliable results. This test represents a significant step forward in the personalized treatment of neurological conditions, offering hope to many individuals and families affected by these challenging disorders.
The SCN1B gene is associated with a condition known as Generalized Epilepsy with Febrile Seizures Plus Type 1 (GEFS+1). This genetic disorder is characterized by a broad spectrum of seizure types that can vary significantly in severity among affected individuals. The SCN1B gene plays a crucial role in the functioning of sodium channels in the brain, which are essential for the proper transmission of electrical signals. Mutations in the SCN1B gene can disrupt these channels, leading to the development of epilepsy and related seizure disorders.
To diagnose this condition and understand its genetic basis, a specialized genetic test targeting the SCN1B gene can be conducted. At DNA Labs UAE, this test is available for individuals who may be at risk of GEFS+1 due to their family history or for those who exhibit symptoms suggestive of this condition. The test involves analyzing the DNA to identify mutations in the SCN1B gene that are known to be associated with the disorder.
The cost of the SCN1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 1 Genetic Test at DNA Labs UAE is 4400 AED. The test provides valuable information that can aid in the diagnosis and management of the condition, enabling healthcare providers to tailor treatment plans more effectively for those affected. Additionally, understanding the genetic underpinnings of GEFS+1 can offer insights into potential risks for family members and inform decisions regarding genetic counseling.
The SCN1A gene Generalized Epilepsy with Febrile Seizures Plus Type 2 (GEFS+2) genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the SCN1A gene. This gene plays a critical role in the functioning of brain cells by coding for a subunit of the sodium channel, which is essential for the transmission of electrical signals in the nervous system. Mutations in the SCN1A gene are associated with various epilepsy syndromes, including GEFS+2, which is characterized by a spectrum of seizure types that range from mild febrile seizures to more severe forms of epilepsy.
The test is particularly important for individuals who have a family history of GEFS+2 or exhibit symptoms suggestive of this condition. By analyzing a sample of the patient's DNA, the test can confirm the presence of mutations in the SCN1A gene, providing valuable information for diagnosis, management, and treatment planning. This can also offer insights into the risk of epilepsy in family members and the likelihood of passing the condition to offspring.
The cost of the SCN1A gene Generalized Epilepsy with Febrile Seizures Plus Type 2 genetic test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the specific expertise required to interpret the results, it represents a critical investment in the accurate diagnosis and tailored management of epilepsy syndromes associated with SCN1A mutations.
